The improvement of the pharmaceuticals’ sales allowances (margins) to pricesregulatory system on medicine included in The Vital and Essential Drugs List
The article discusses and supports alternatives to improve the Russian regulatory system of sales allowances to pricing on pharmaceuticals , included in the Vital and Essential Drugs List; which were developed by means of analytical research in order to encourage sales of cheaper pharmaceuticals and price decreases on expensive ones. In addition, based on the world practice, possible ways of the state regulation of pharmaceutical maximum margins are highlighted and suggested the most appropriate for domestic pharmaceuticals distribution system.